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INTRODUCTION 
There is much we do not know about nanotechnology (NT). Despite its 
tremendous promise, NT today is mostly forecast and fervent hope. Predictions that NT’s 
value will increase from current levels of $13 billion to more than $1 trillion by 2015 are 
no more than that, predictions.1 Hopes that NT will go far toward solving the globe’s 
energy, food, and water problems2 are tempered by a century of revolutionary 
technologies that failed to live up to their early promise. Many other questions continue 
to nip at NT’s heels – not the least of which concern what is or is not technically 
feasible.3 Despite these uncertainties, we can have complete confidence in one aspect of 
NT’s future: it will be subject to a host of regulations.  
Indeed, the NT industry is already regulated in some ways. Funding policies and 
decisions function as ad hoc regulatory systems, allowing some areas of research to 
flourish while others wither. Some aspects of NT will also fall under existing regulations 
or forms of oversight.4 Yet we can expect that informal regulation and extensions of 
current regulatory schemes will eventually be replaced by more formal and directed 
regulatory frameworks that seek to cabin NT’s risks, promote its benefits, and temper its 
social and economic impacts. What is more, because much of the promise and many of 
the potential pitfalls of NT are transnational in scope, we must consider not only national 
regulation in individual countries, but also the potential for regulation by multiple nations 
– almost certainly inconsistent, if not conflicting, in the absence of coordination – and for 
transnational regulation of varying forms. 
Much of this regulation, both national and transnational, will be adopted in the 
form of law. Law has long been the interface between science, technology and regulation. 
Legal frameworks developed for other scientific innovations – from common law 
property and liability rules to more elaborate regulatory approaches – may well be 
applied to NT, or provide models for its regulation. Hence we believe that law as a 
discipline is essential to the study of future NT regulation, although it has to date been 
largely silent on the subject. Some legal scholars have begun considering the regulation 
of NT,5 and a few have focused on specific solutions to transnational NT problems.6 Yet 
there has been little general discussion of transnational regulatory frameworks, with most 
authors focusing solely on NT’s intellectual property implications.7 
Because of the unique characteristics of the international system, we believe it is 
also essential to introduce an international law (IL) perspective into the study of 
transnational NT regulation. The sub-discipline of IL builds on general legal principles 
and understandings, but takes account of the political and institutional realities of 
international affairs and focuses on the mechanisms characteristic of transnational 
governance. In recent years, moreover, IL has engaged deeply with the discipline of 
international relations (IR) after decades of separation.8 The resulting interdisciplinary 
IR-IL perspective is well-suited to addressing questions of institutional design. As one of 
us has written, “IR helps lawyers and other policy makers to analyze social problems in 
theoretically informed ways and develop a wide range of ameliorative responses.” 9  
This paper represents a very early stage of a collaborative research project on 
transnational NT regulation. In this project, we seek to apply the rich multidisciplinary 
perspective just described. At this preliminary stage, however, we do not purport to offer 
firm conclusions or recommendations. Instead, we set more modest goals.  
We begin in Section I by considering the nature of NT and some risks it may pose 
as it is more fully developed and utilized over time. We next consider the nature of 
transnational “regulation,” suggesting the range of legal, institutional and substantive 
forms this term can encompass. Because NT and its regulation are (like our project) at 
such early stages of development, we emphasize the importance of regulatory flexibility.  
In Section II, we consider a series of strategic choices that must be faced in 
designing transnational regulation in any issue area, including NT; these include the level 
and scope of regulation, the actors authorized to promulgate regulatory norms, the legal 
and institutional form of regulation, and finally its substantive content.  
In Section III, we argue that it is useful, although not definitive, to study models 
of transnational regulation developed for similar issues arising out of other forms of 
technology. While few if any of these models will be directly applicable to the unique 
characteristics of NT, the designers of these regulatory regimes faced similar strategic 
choices as well as similar problems, and the models they created can offer useful lessons. 
We briefly discuss a few potential models to illustrate the approach. Our larger research 
project will expand the study of transnational models beyond those discussed here, with a 
view to developing more specific recommendations for NT regulation.  
Consistent with our emphasis on regulatory flexibility, we conclude by tentatively 
suggesting a sequencing of regulatory approaches designed to allow NT regulation to 
develop over time into broader, more elaborate and more highly legalized form as we 
gain greater knowledge of, and experience with, the benefits and costs of NT.  
 
II. NANOTECHNOLOGY, RISK AND REGULATION 
A. NT and Its Potential Risks. 
NT, which involves the manipulation of particles, structures, and devices at the 
scale of 1 to 100 nanometers, is often described as “the next big thing” (Feynman, 1959). 
In terms of funding, there is very little “next” about it. Over a dozen countries – from the 
United States, the EU and Japan to China, Taiwan and Korea – are heavily engaged in 
NT R&D, and in most of those countries governments actively support and coordinate the 
work (IRGC 2005). An increasing share of the US government’s more than $100 billion 
annual investment in R&D (Guston, Woodhouse & Sarewitz, 2001) is being allocated to 
NT (Roco, 2003; Melman, 2002), and industry forecasts predict NT’s future at more than 
$1 trillion in less than a decade (Roco & Bainbridge, 2001; Enabling, 2005). Indeed, 
estimates of annual worldwide investment in NT already exceed $3 billion (Nanotech 
Report, 2003). Yet while the “bigness” of NT usually refers to its potential applications 
and benefits, the term could also refer to the challenges and opportunities NT presents for 
national and transnational regulation.  
While NT is still an emerging technology, observers have identified a range of 
potential health, safety and environmental risks (Colvin, 2003; Michelson, 2004), based 
both on initial toxicological tests and by analogy to particulates such as asbestos or 
carbon dust (Calderon-Garciduenas, 2002; HSE/NIOSH, 2004; Mark, 2004; Oberdorster, 
2004; Swiss Re, 2004). The unique characteristics of nanomaterials, which provide many 
of the potential benefits and much of the excitement about NT, may also result in unique 
and previously unpredicted toxic effects. Researchers, workers and consumers (CRN, 
2003; ETC, 2002 & 2003) may be at special risk.  
Others have focused on the potential for misuse and mayhem in the application of 
NT. As a classic dual-use technology, NT may have significant military uses, and even 
hold potential for terrorists (CRN, 2003; Drexler & Phoenix, 2004). Observers further 
agree that the NT revolution could disrupt economic conditions around the globe (CRN, 
2003), while increasing the gap between developed and developing nations (Wolfson, 
2003; Luther 2004). Some argue that governments could use NT to curb civil liberties 
(Mnyusiwalla, 2003). NT may pose ethical issues by extending life and otherwise 
transforming biological systems. At the current stage of NT’s development, none of these 
risks has come to pass, yet some feel threatened by the very uncertainty and opacity of 
future developments, concluding either that progress should be halted before it is too late 
or that steps should be taken to allow society to act quickly as specific risks are observed. 
At the same time, poorly designed NT regulation, justified by such risks and fears, 
would create significant problems of its own. Inappropriate regulation in any one country 
would impose unnecessary costs on researchers, firms and potential users there, slowing 
development and commercialization. Inconsistent national regulation – whether reflecting 
distinct nomenclatures and standards or substantively different policy choices – would 
multiply the costs, hampering international commerce as well as research, development 
and commercialization. Subsidies, especially if competitive, would impose other 
economic and social costs and skew the trajectory of development.  
Crucially, most of these issues will be transnational in scope. As science and 
business globalize, research and industrial collaborations will become multinational. 
Health and safety risks will cross borders, carried by traded products or resulting from 
scientific and industrial processes. They may affect global commons, such as the 
atmosphere and the seas. Military and terrorist uses raise obvious international concerns. 
Other disruptive innovations such as biotechnology, moreover, offer many examples of 
transnational social, political and economic conflict, including protectionism and trade 
disputes (e.g., between the US and the EU over genetically modified foods), intellectual 
property disputes, and concern over the equitable distribution of benefits across countries.  
Table 1 suggests the range of potential problems arrayed roughly along the likely 
life cycle of the technology, with pervasive uncertainty and R&D issues currently on the 
agenda, and more concrete and serious risks likely to appear further in the future. 
Table 1 
Nanotechnology Issues  
With Transnational Dimensions 
Along Technology Life Cycle 
 
 
 
1. Uncertain, unknown future risks; 
Social flexibility to address future risks 
 
 
2. R&D/ information flows 
 
 
3. Broad ethical concerns 
 
 
4. Manufacturing operations – e.g. OSH 
 
 
5. Environmental release 
 
 
6. Social/economic concerns 
 
 
7. Inappropriate regulation 
 
 
8. Human health – e.g. medical uses 
 
 
9. Intentional misuse – e.g. terrorism 
 
 
 
Experts from various disciplines have weighed in on the wisdom of NT 
regulation, some advocating stringent controls (ETC, 2002; ETC, 2003; Joy, 2000; 
Dearne, 2004), others a hands-off approach (Wolfe, 2005). Some have addressed 
specifically transnational risks and opportunities. Dr. John Marburger, the President’s 
Chief Science Advisor, has highlighted several transnational issues, including 
harmonization of standards, intellectual property protection, oversight and regulation of 
hazards and North-South benefit sharing (Meridian, 2004). Others have also discussed 
these issues (HSE/NIOSH, 2004; Luther, 2004; Roco & Bainbridge, 2005; Berube, 2005; 
Royal Society, 2004). Recent publications have heightened the public’s attention both to 
the overhyping of nanotechnology (and its potential failures) (Berube, 2005) and to its 
potential dangers to health and human safety (Davies, 2005).  
Yet transnational responses remain in their infancy. An International Risk 
Governance Council survey identified no international agreements, and few formal 
transnational arrangements of any kind, that specifically address NT, except for technical 
work in the ISO (IRGC, 2005). As one expert has noted, “We need an international 
nanorisk research program built on shared knowledge and a clear set of priorities” 
(Service, 2005). Despite this felt need, to date most transnational activity has involved 
merely exploratory discussions, convened by national agencies (e.g., US NIOSH), 
international organizations (e.g., OECD), and research groups (e.g., Meridian Institute). 
In one significant gathering, held in June 2004, Meridian and the National Science 
Foundation convened representatives from twenty-five national governments and the EU. 
The group called for continued dialogue and coordination on NT R&D, and agreed to 
meet annually as the International Dialogue on Responsible Research and Development 
in Nanotechnology (Meridian, 2004). Yet as this call for dialogue suggests, much 
remains to be done to develop workable and responsible transnational NT governance. 
B. Transnational “Regulation” 
We use the term “regulation” expansively. Scholars in law and public 
administration now recognize and support social interventions much more varied than the 
welfare state model of command-and-control regulation built around mandatory law, 
specific prohibitions, expert agencies and centralized enforcement (Ayers & Braithwaite, 
2002; Gunningham, 1999; Freeman, 1997). Numerous government programs in the US, 
the EU, Australia, Scandinavia and other areas are built around new approaches to social 
ordering, often drawing on private sector management techniques.  
According to one scholar, these wide-ranging developments reflect a common 
paradigm that favors “governance” over “regulation” (Lobel 2004; but see Karkkainen 
2004). Among other principles, the governance paradigm favors (i) transferring authority 
for the promulgation and implementation of norms to lower levels of government (as 
does the principle of subsidiarity) and to non-state actors, subject to various forms of 
state orchestration (e.g., policy steering, audited self-regulation; Wood 2002-03); (ii) 
flexible policies and rules, including “soft law,” negotiated rule-making and even non-
binding private norms arising, e.g., from business self-regulation; (iii) reliance on 
information disclosure, incentives and market forces; and (iv) an ethic and process of 
continuous improvement. 
Transnational “regulation” already resembles the governance paradigm in many 
ways. To be sure, treaties and many other international agreements are publicly created 
and legally binding; a growing number are also legalized in other ways, e.g., with quasi-
judicial bodies authorized to apply agreed rules (Goldstein et al., 2001). International 
organizations are often charged with implementing agreed rules, analogous to domestic 
administrative agencies (Abbott & Snidal, 1998). Indeed, significant recent research in IL 
focuses on similarities to domestic administrative law (Kingsbury et al., 2005). 
Yet international governance still differs from traditional regulation in many 
ways. Because states are jealous of their sovereignty, “soft law” is widely used, much 
more often than in domestic regulation. While soft law represents a political or moral 
commitment, it does not impose legal obligations. As a result, its use may facilitate 
agreement among states with differing interests, especially in conditions of uncertainty. 
Similarly, states often favor informal arrangements for information sharing and 
discussion among peers, rather than binding rules; peer networks are often created and 
managed by national regulators rather than “states” as such (Slaughter, 2004).  
 
 
C. Permissive and Prophylactic Regulation 
One further distinction is important at both the domestic and the transnational 
levels: regulatory responses may be either “permissive” or “prophylactic.” Both types 
have been proposed in recent debates about the future of NT. 
When we think of “regulation,” we often think solely of negative prescriptions 
and proscriptions — requiring researchers or business firms to meet certain standards, 
creating administrative mechanisms to monitor their behavior, or even prohibiting certain 
areas of research or production entirely. Yet regulation can also play a more positive role: 
giving researchers and firms clear guidelines about what practices and areas of activity 
will be permitted and, just as important, what frameworks will govern the results of their 
endeavors. Such permissive regulation addresses one of the chief impediments to the 
success of a technology like NT: economic and regulatory uncertainty. 
Funding programs that promote specific areas of research carry with them the 
implicit promise that such research may be continued in the future. The imprimatur of 
government may also facilitate private funding, as evidenced by the rapid rise in venture 
capital investment in NT since the US government launched its NNI initiative in 2001,10 
or the rapid increase in biotechnology funding after the Supreme Court’s decision in 
Chakrabarty11 and passage of the Bayh-Dole Act both in 1980.12 Regulation can build 
public and consumer confidence in a technology.13 Permissive regulation can also create 
a framework for coordination between units of government. Such frameworks help 
competing agencies pool resources, signal to industry the agencies and rules that will 
govern their activities, and avoid inter-agency or transnational disputes. In short, tailored 
regulations can play a positive role in promoting a technology’s growth. 
The more traditional role for regulation is as a prophylactic against potential 
dangers. Prophylactic regulations cover a broad spectrum of restrictiveness. At one end, 
they may merely require the reporting and review of new technologies before their 
introduction. The US Bureau of Industry and Security, for example, currently requires 
notification of all new encryption technologies prior to export.14 More stringent 
regulations may require pre-market approvals by administrative agencies, such as the 
Food and Drug Administration’s (FDA) review of new pharmaceutical for risk and 
efficacy.15 At the opposite end of the spectrum are regulations that prohibit or establish 
moratoria on certain kinds of activity.16 Prohibitions on funding some kinds of stem-cell 
research,17 on research into human cloning,18 and on the sale or export of genetically 
modified foods19 are examples.20 
D. Regulate Now or Regulate Later? 
Many of the suggested risks of NT are either hypothetical or remote, in terms both 
of probability and of time. Yet there are plausible arguments for acting now rather than 
waiting until concrete threats have appeared. Growing public concern over NT carries the 
risk that failing to act will allow this technology to develop into “another Frankenfood 
controversy,” with NT stigmatized to the point that the public will not accept proof of its 
safety.21 Some advocacy groups22 have already called for a moratorium on NT 
development in accordance with the precautionary principle, until the technology is 
proven safe.23 According to Douglas Parr, chief scientist of Greenpeace: “with the 
precautionary principle applied, these materials should be considered hazardous until 
proven otherwise.”24 From a permissive perspective, the failure to regulate breeds 
uncertainty about NT’s future and chills investment and research. From the prophylactic 
perspective, regulating now would allow society to “keep the genie in the bottle,” 
shielding society from the most dangerous possibilities. 
Yet many of these same factors may militate in favor of deferring action. On one 
view, given the nascent state of NT, regulatory debates and enactments may distract 
researchers and policymakers from the more pressing imperatives of funding and 
development.25 Attempting to regulate in the face of great uncertainty will only chill 
research and innovation. Regulatory discussions conducted with little real knowledge of 
NT’s capabilities and dangers may undercut the public’s still generally positive opinion 
of the technology.26 Should the assumptions of early action turn out to be incorrect, the 
legitimacy of experts and policy makers could be undermined.27 Finally, regulations often 
reflect sub-optimal compromises, even in more certain conditions; once enacted, 
however, they may be difficult to amend, casting a regulatory shadow far into the future.  
 
 
 E. Flexible Transnational Regulation 
Our tentative conclusion, explored further below, is that – assuming that some 
form of transnational regulation is deemed appropriate – preliminary and flexible forms 
of regulatory action would be most suitable under current conditions. A flexible approach 
is clearly compatible with transnational political realities: states and other international 
actors typically act in tentative or exploratory fashion when the nature of a problem or the 
politics or capacities of actors are uncertain. 
Consistent with the governance paradigm, the most tentative approach – although 
not necessarily the most flexible – involves reliance on non-state actors to generate initial 
understandings and norms; once a polity has gained experience with these private norms, 
public authorities can override or ratify them as appropriate. This approach draws on the 
expertise and experience of the actors most directly involved in research, development 
and commercialization; one can also expect those actors to update norms as their 
knowledge advances. Researchers, and increasingly business firms, operate within a web 
of professional norms that exerts some discipline on rule-making. Still, the self-
interestedness of private actors creates concern, and their questionable legitimacy as rule-
makers can weaken public acceptance of private norms. 
A public form of exploratory transnational governance, especially useful in the 
early stages of cooperation, involves informal arrangements for research, information 
sharing, dialogue and peer review among national regulators or other technical agencies. 
Such arrangements frequently involve private actors – such as research organizations and 
business associations – in many of their activities, incorporating a broader range of 
expertise and viewpoints. Once common positions or “best practices” are identified, they 
might be adopted as transnational soft law; even soft international standards help guide 
independent national decisions on permissive or prophylactic regulation. 
Beginning with soft law – such as transnational recommendations, guidelines or 
standards – provides another avenue for policy flexibility (Abbott & Snidal, 2001). The 
use of soft law, however, presumes that states have some idea of the appropriate 
substantive content of regulation; it is therefore particularly useful when policy-makers 
are uncertain about the social or economic impact of rules or the political reactions of 
interest groups or the public, rather than about the nature of a problem or potential 
solutions. States can establish processes that allow them to progress gradually toward 
more binding agreements as they gain certainty (Abbott & Snidal, 2004).  
When the technical nature of a problem is uncertain – as is the case with NT – 
even more highly legalized transnational arrangements can take exploratory form. 
“Framework conventions” offer a particularly valuable approach. These are legally 
binding treaties that establish limited initial obligations – typically for research, 
information sharing, dialogue and the like – with the expectation that the parties will add 
more specific substantive commitments over time as they learn about the problem and 
potential solutions, achieve consensus and develop trust (Brunnee & Toope, 1994). In 
addition, framework conventions typically provide expedited procedures for adding 
substantive commitments in the form of “protocols” or other follow-on instruments. This 
approach is widely used in environmental law (e.g., the Framework Convention on 
Climate Change/Kyoto Protocol), and has come to be used in other areas, such as public 
health (e.g., the Framework Convention on Tobacco Control; Taylor, 1996). 
When the interests or regulatory capacities of particular states are in question, 
initial agreements may be limited to small groups of states (e.g., OECD members), with 
the hope of adding additional parties over time as their interests and capacities become 
clear. Many treaties also apply the equitable principle of differentiated obligations, for 
example, by imposing weaker obligations on poor countries (Stone, 2004). 
 
III. STRUCTURAL CHOICES FOR TRANSNATIONAL REGULATION 
In considering possible forms of transnational NT regulation – in the broad sense 
of the term outlined above – a number of strategic decisions must be made. (On 
transnational institutional design, see, e.g., Koremenos, Lipson & Snidal, 2003; Mitchell 
& Kailbach 2001.) Public attention is typically focused on the shaping of substantive 
rules, but there are many structural and formal attributes that must be agreed upon in 
designing a regulatory regime. We suggest here some of the most important issues. 
A. National vs. transnational action.  
The threshold question is whether some form of transnational regulation aimed at 
promoting or controlling NT research, development and exploitation – or at constraining 
national regulatory choices that might produce economic costs and diplomatic friction – 
would be desirable, or whether society would be better served by leaving regulation 
entirely to individual states. Each approach has advantages and disadvantages.  
National regulations can be closely tailored to the level of technical and economic 
advancement and the social preferences of each polity. At a systemic level, moreover, 
diverse national approaches allow for experimentation; others can learn what works and 
what does not. Ideally, national regulation will promote beneficial competition, leading 
states to “trade up” to socially superior outcomes (Vogel & Kagan, 2004; Vogel, 1998). 
In practice, of course, competition may instead result in a “race to the bottom,” as 
advocates allege is occurring on environmental and labor standards. Even short of a 
“race,” national officials tend to ignore transnational impacts, since foreign citizens do 
not vote locally. Similarly, national regulators may yield to protectionist or alarmist 
demands when they can externalize the costs onto foreign researchers and producers. 
National officials (at least those from “have” states) acting alone are unlikely to volunteer 
an equitable sharing of resources or benefits with “have-nots.” Inconsistent national 
regulation creates burdens for transnational researchers and firms. And uncoordinated 
regulation may be poorly suited to address potential security threats arising from NT. 
Most new technologies have been subject only to national regulation. For many, 
this has not appeared to hinder progress, although the counterfactual is difficult to 
establish. Human genomic sciences and many of their applications, for example, have 
flourished without substantial transnational coordination. Other technologies, however, 
have been less fortunate: genetically modified foods (“GMOs”), notably, have faced 
widely varying social attitudes and laws, producing a substantial burden on researchers 
and producers, allegations of protectionism and trade conflicts. Without hazarding an 
overall conclusion on the merits of the GMO case, there can be little doubt that the 
technology has suffered because of disparate regulation.28  Stem cell research is another 
technology where divergent national regulations are impeding orderly development. 
B. Optimal Scope of Transnational Regulation 
If it is determined that some form of transnational regulation is desirable, a related 
design choice is the scope of the regulatory regime, which can be equated to its breadth 
of participation. Regulation of any kind is most effective when its scope is congruent 
with the issue being addressed; thus for most issues there is an optimal scope, although it 
may be difficult to achieve in actual negotiations. Table 2 indicates the principal 
alternatives; it suggests that the national/transnational choice is the most significant of all. 
 
Table 2 
Scope of Regulation 
 
 
Multilateral 
 
 
Plurilateral 
 
 
Bilateral 
 
. . . . 
 
Unilateral – national action
 
 
1. For some issues, broad multilateral participation may be necessary (e.g., global 
warming) or desirable (e.g., international trade).  
2. For other issues, agreement among smaller groups of states – such as the 
industrialized countries – may be sufficient (e.g., control of high-technology exports). A 
finely-tuned plurilateral approach is difficult to achieve, however, unless negotiations can 
be pursued in an organizational forum whose membership matches the relevant group of 
states; where no such forum exists, it may be necessary to create a new institution, a 
costly endeavor. Given the range of nations currently investing in NT, the lack of an 
appropriate forum may well be a problem in the case of this technology.  
3. Bilateral agreements may even suffice for some issues (e.g., taxation).  
Each form has strengths and weaknesses in addition to congruence with the 
underlying issue. For example, a multilateral agreement can produce greater 
harmonization, inclusiveness and equity (e.g., by including developing countries), but it 
is more costly and difficult to negotiate. The narrower the scope of each particular 
regulatory arrangement, the greater the latitude for experimentation and competition in 
the system as a whole; however, this latitude comes at the expense of harmonization, and 
often of equity: bilateral trade and investment agreements, for example, are often pursued 
by powerful countries seeking to “pick off” vulnerable partners one at a time.  
Since NT poses such a host of potential issues, it would not be surprising if 
multiple agreements of different scope constituted the optimal response. But this raises a 
related structural issue: it is often easier to reach an international agreement when a 
number of issues are linked in negotiations, allowing trade-offs across issues. Thus there 
may be an optimal scope in terms of issues as well as participation. States should not 
hastily split off different issues into unrelated negotiations.  
C. Norm-generating Actors 
In traditional IL, rules were adopted by states and were applied to states; it was up 
to each government to apply agreed rules to actors within its jurisdiction, a principle that 
allowed for a great deal of “slippage.”  In recent decades, however, other actors have 
come to play an increased role in international governance, specifically in the adoption of 
international rules and standards. “Transgovernmental” arrangements among national 
regulators, discussed above, are of growing importance in fields ranging from finance to 
food and drug regulation. Through these informal and flexible arrangements, expert 
regulators share information and “best practices,” harmonize rules and procedures, assist 
one another in enforcement proceedings and resolve disputes. Specialized regulators can 
easily develop distinct sets of regulatory norms for different areas of concern. This could 
be a highly attractive option for many aspects of NT. 
Even more remarkable is the growing role non-state actors and the “transnational” 
normative arrangements they produce. At least three types of private regimes hold 
promise for the early-stage regulation of NT:  
1. Transnational “epistemic communities.” These are groups of individuals who 
share common causal understandings of some area of activity, often scientific, 
and may share common values as well. Community members work in national 
agencies, international organizations, NGOs, research labs or other institutions. 
Communities can be organized by professional associations, international 
organizations or on an ad hoc basis. Epistemic communities are especially 
valuable in highlighting scientific problems (e.g., damage to the ozone layer, 
global warming), disseminating objective information and proposing 
knowledgeable solutions.  
2. Self-regulatory arrangement by researchers – following scientific and 
professional norms – and by business firms – following norms of corporate social 
responsibility; and  
3. Public-private partnerships.  
Table 3 indicates the range of actors that today are engaged in transnational 
“regulation,” broadly defined. Virtually all of these actor groups can create 
transnational norms at lower cost than traditional interstate treaties, draw on 
expert knowledge and professional norms, operate on a decentralized and flexible 
basis, and lend themselves to continuous learning. Governments need not abdicate 
responsibility entirely when non-state actor regimes are formed; public agencies 
can oversee and shape all types of private regimes through techniques like those 
noted above (Wood, 2002-03).  
Table 3 
Transnational Actors 
 
 
States 
 
 
National regulatory agencies
 
 
Public-private 
partnerships 
 
 
Epistemic communities 
 
 
Researchers, business firms 
 
 
D. Legal Form and Institutionalization 
We have spoken frequently of “soft law.” For agreements or regimes created by 
states, the principal choice in terms of legal form is between some form of soft law and 
“hard” IL. Yet it is important to note that this is not a binary choice: agreements can be 
“softened” along multiple dimensions (Goldstein, 2001; Abbott & Snidal, 2000). For 
example, many international agreements contain strong rules, but provide few procedures 
for implementation, follow-up or dispute resolution. Framework conventions provide 
another alternative. The initial treaty is formally a “hard,” legally binding agreement, but 
it contains little substance. Even here states have choices: for example, they can include 
in the initial framework agreement only provisions for consultations and information 
sharing, or they can prescribe clear principles for future actions and initiate a dynamic 
process designed to strengthen cooperation over time.  
Transgovernmental arrangements generally constitute soft law, as they are not 
entered into in the name of the state. Indeed, avoiding the costly national government 
approval processes required for legal commitments is a primary rationale for this 
approach. Within this constraint, many forms of interaction are possible: an agreement on 
information sharing, for example, will be more informal than one on legal assistance. 
Private self-regulatory arrangements take diverse forms, such as 
recommendations and guidelines. Many professional1 and business2 organizations 
promulgate “codes of conduct,” varying from brief statements of aspiration to elaborate 
systems of rules with external monitoring procedures. Specialized monitoring 
organizations, both profit-seeking and non-profit, have sprung up to service such codes. 
Public–private partnerships often promulgate rules that closely resemble law, in form if 
not in effect. An example is the UN Global Compact, which enlists business firms to 
voluntarily implement principles drawn from multilateral treaties.  
Institutional arrangements are an important aspect of regime design, and are often 
closely related to the level of legalization. A formal organization has significant 
advantages for a regulatory regime. It allows for centralization of administration, 
                                                 
1 http://onlineethics.org/codes/ 
2 http://www.bsr.org/CSRResources/IssueBriefDetail.cfm?DocumentID=50303 
facilitating negotiations, technical assistance and other activities. Additionally, a formal 
organization can be granted some independence, allowing it to produce and disseminate 
unbiased information, allocate resources fairly and mediate disputes. But the costs of 
creating and maintaining a formal organization are high. Increasingly, transnational 
regulation – especially when administered by government agencies, non-state actors and 
public-private partnerships – is structured around more or less informal networks. 
Networks sacrifice some of the benefits of centralization and independence, but provide 
increased flexibility, adaptability, and low operating costs.  
 
Table 4 
Legal/Institutional Form 
 
 
 
Interstate regimes: 
 
 
     Hard law/strong institutions 
 
 
     Soft law/weak institutions 
 
 
Interagency networks: 
     soft law 
 
 
Public-private partnerships: 
     soft law 
 
 
Non-state actors:  
     self-regulatory codes of conduct 
 
 
E. Substantive Content 
Substantive obligations are crucial to any regulatory arrangement. Yet it is 
difficult to generalize as to the range of choice in these matters: transnational rules and 
implementation activities can be as varied as the problems they address. Referring back 
to Table 1 and the accompanying discussion, NT presents an extraordinarily varied set of 
substantive problems, at least hypothetically. Substantive rules, whether permissive or 
prophylactic, must be drawn with a full understanding of these risks, including their 
political, economic and social aspects as well as their technical underpinnings.  
One way to gain analytical purchase on this question is to consider the underlying 
situation structure of each issue. While NT may pose a wide range of potential risks, 
these may be categorized into a smaller number of problem types, each of which may 
require particular forms of regulation.  
 To illustrate, consider several examples: 
1. If the problem to be addressed is defined as a transboundary harm, as with 
many forms of pollution and the spread of infectious diseases, substantive obligations 
will focus on preventing or limiting passage of the harmful agent across national borders, 
and providing for a response if such passage takes place. In most cases regulations will 
not need to restrict research, commercialization, or production of the substance. Related 
activities might include monitoring of transboundary flows (e.g., through trade or in the 
atmosphere), and technical or financial assistance to states that lack capacity to prevent 
transboundary flows or to respond as needed. Similar provisions are characteristic of 
transnational denial regimes, such as export controls on dual-use technologies relevant to 
conventional weapons (e.g., missiles), weapons of mass destruction or terrorism. 
2. If the problem is defined as the safety of researchers, workers and others 
exposed to nanomaterials, very different rules will be required. Here the nature of the 
problem is two-fold: transnational regulation is seen as appropriate in order to promote 
human rights, even in states that might not do so on their own, and to limit economic 
competition on the basis of lax national standards. Transnational labor regulation, e.g., 
ILO rules on wages, working conditions and occupational safety and health, responds to 
such problems. Transnational rules might therefore set harmonized minimum standards 
for safe exposure and remediation in the workplace. Related activities might include 
monitoring, technical assistance, research on permissible exposures and alternate 
processes, and support for negotiations. 
3. If the problem is defined as a risk of widespread harm to human health, or 
to global commons such as the atmosphere, from the release of a dangerous substance, 
substantive obligations would have to address the full product cycle, from R&D through 
production. They might set standards for the safe conduct of such activities (or in extreme 
cases prohibit them), require public notice in the event of a release, and provide for 
compensation, penalties or other incentives. Related activities might include licensing, 
surveillance, information disclosure, consultations, research on risks and responses, and 
technical/financial assistance.  
4. If the problem is defined as one of international equity, like the “digital 
divide” in computer technology, regulation would aim to impose affirmative substantive 
obligations to assist less-advantaged nations through technical assistance, transfer of 
technology, financial aid, trade benefits or other means. 
5. If a problem or its extent remains undefined, a framework convention or 
similar exploratory approach might be appropriate. Under the circumstances, such an 
agreement will contain few firm substantive obligations, although it might spell out basic 
principles (e.g., differentiated obligations, non-discrimination in trade) to be followed in 
future substantive agreements. As noted above, framework convention activities typically 
provide for coordinated research, information sharing, consultations, technical and 
financial assistance, and support for negotiations. 
Because the alternatives for substantive regulation are so diverse and problem-
driven, we believe that the most fruitful way to proceed is through consideration of actual 
regulatory regimes that address technologies with features analogous to NT. We elaborate 
this approach in the following section. 
 
 
 IV. Models of Transnational Regulation 
 If and when it is decided that NT regulation is justified, and if and when it is 
determined that transnational regulation is appropriate, actors can look to a broad range 
of regulatory regimes designed for other technologies as models. Some regimes will be 
relevant because they focus on substantive problems analogous to those associated with 
NT, such as environmental agreements aimed at transboundary harms or arms control and 
non-proliferation regimes. Others will be relevant because they utilize mechanisms – 
such as framework conventions or private codes of conduct – that appear useful for NT 
regulation. Given the unique characteristics of NT, it is doubtful that any existing regime 
would fit it precisely. Nevertheless, regulatory regimes designed for other technologies 
can provide valuable analogies and lessons. We summarize here pertinent aspects of 
several regulatory regimes that may be relevant models for NT regulation at different 
stages in the development of the technology. 
A. Potential models for the long term 
Most well-known transnational regulatory regimes are relatively strong on most 
of the design criteria discussed here: they are typically created by interstate agreements, 
take the form of binding IL, are at least moderately institutionalized, and contain fairly 
rigid substantive rules. (Nonetheless, even these regimes are widely criticized for their 
weakness, based on substantive vagueness or loopholes, weak implementation, and 
inadequate monitoring and enforcement.) As a result, their lessons will be most valuable 
in the future, when the risks of NT development have become far more clear. 
 1. International Agreements on Environmental Pollutants 
 Several multilateral agreements restrict or prohibit the production and use of 
specific toxic substances based on their harmful effects on important components of the 
global environment. In terms of the problem structures introduced in the previous section, 
these agents threaten widespread harm to human health or to global commons. Examples 
include the Stockholm Convention on Persistent Organic Pollutants29 and the Montreal 
Protocol on Substances that Deplete the Ozone Layer.30 Treaties of this sort tend to focus 
on a relatively small number of agents that present well-demonstrated and substantial 
risks. For example, the Stockholm Convention as initially adopted in 2001 banned 
production and use of twelve substances (referred to as the “dirty dozen”) that are highly 
toxic, persistent and accumulative, and can move long distances in the environment. All 
participating states were quite prepared to ban them, if they hadn’t already.31  
The most controversial part of the Stockholm Convention is its provision for 
adding additional substances in the future. (The Montreal Protocol, itself an expansion of 
the Vienna ozone convention, and other environmental agreements include similar 
provisions; in that regard all resemble framework conventions.) This critical provision – 
notably the criteria and procedures for designating additional pollutants – has been the 
focus of much disagreement amongst signatories and potential signatories;32 it has been 
the primary impediment to US Senate consent to the convention.   
Because they focus on a limited set of very hazardous agents, agreements like 
Stockholm tend to impose strict substantive restrictions, often in the form of a full or 
partial prohibition of production or use. This contrasts with most national environmental 
laws, which prescribe acceptable levels for many pollutants. The combination of limited 
scope and substantive stringency likely reflects the cost and difficulty of negotiating 
binding international agreements, which make them feasible only for particularly harmful 
substances that all agree should be restricted.  
Indeed, agreement is often possible only once the industries that produce the 
target substances agree to phase out production. For example, the Montreal Protocol 
became feasible only after DuPont, the principal manufacturer of chlorofluorocarbons 
(CFCs), the primary focus of the Protocol, identified commercially feasible alternatives 
and agreed to stop producing CFCs. Without industry agreement, negotiations can drag 
on indefinitely. For example, the United Nations Environmental Program (UNEP) has for 
years been promoting a treaty on mercury in the environment, without success.33 
Other international environmental agreements are designed to limit or regulate the 
transboundary movement of pollutants – in the air, in water or as transportable solids. 
Examples include the European Convention on Long-Range Transboundary Air Pollution 
(LRTAP)34 and the Basel Convention on Transboundary Movements of Hazardous 
Wastes and Their Disposal.35 While transboundary agreements have a narrower 
substantive focus, as discussed above, and need not impose bans, they are still difficult 
and costly to negotiate. As a result, they too tend to focus on pollutants that are prevalent 
in the environment and known or strongly suspected of causing significant damage. 
These characteristics suggest that international environmental agreements have 
limited applicability as models for NT regulation in the near term. Given the political and 
practical impediments to successful negotiations, states have only demonstrated the 
necessary commitment in dealing with a limited set of harmful substances. It is difficult 
to imagine states undertaking such a burdensome process to address the hypothetical risks 
of future NT products or processes that have yet to inflict any known environmental 
harm; moreover, no known NT applications pose such serious risks that a ban or severe 
restriction seems appropriate. If environmental risks of NT appear in the future, however, 
these agreements will provide important lessons. 
2. Non-Proliferation Arms Control Agreements 
Arms control treaties, especially those that seek to prevent the proliferation of 
weapons of mass destruction (WMD), provide another transnational model of potential 
relevance to NT. Examples include the 1968 Nuclear Non-Proliferation Treaty (NPT),36 
the 1972 Biological Weapons Convention (BWC),37 and the 1993 Chemical Weapons 
Convention (CWC).38 Several aspects of these agreements limit their applicability as 
models for NT.  
First, non-proliferation treaties seek to control technologies (i.e., nuclear, 
chemical or biological weapons, or inputs to them) that are clearly dangerous, as 
indicated by the term “WMD.” Notwithstanding some extreme scenarios, it is unlikely 
that current or near-term applications of NT will rise to the same level of threat. In the 
long term, some NT applications could present a WMD threat, but that is likely far in the 
future. States are unlikely to act until the risks are more concrete and immediate. 
Second, existing arms control treaties only apply to states. Their impact on non-
state actors is indirect at best (e.g., the CWC and BWC require state parties to prohibit 
activities on their territory that are prohibited directly for them). Yet non-state actors, 
particularly transnational terrorist networks, may present the greatest threat of turning NT 
to malevolent uses. Another implication of this statist focus is the requirement of state 
consent; states can choose not to ratify these agreements and can drop out if they join. All 
three WMD treaties have experienced states, often those presenting the greatest threat, 
electing not to ratify the agreement, withdrawing from it, or failing to comply with its 
obligations.39 If a rogue state were to seek to use NT for malevolent purposes, current 
“Geneva style” arms control agreements would likely be ineffective. 
Nevertheless, if predictions as to the potential military applications of NT are 
borne out,40 at some point in the future states may be forced to consider arms control 
agreements to restrain a NT arms race or the aggressive state use of NT for weapons 
purposes, in part because of the lack of good alternatives. In such a situation, current 
agreements do suggest some lessons. 
One of the principal tensions in the NPT results from its two-tier membership 
structure, in which some states – those grandfathered as of 1968 – are permitted to 
possess nuclear weapons while others are prohibited. The Director of the IAEA, 
Mohamed ElBaradei, recently emphasized this tension by stating: “I repeat that it is time 
to abandon the unworkable notion that it is morally reprehensible for some countries to 
pursue nuclear weapons but morally acceptable for others to rely on them.”41 The lesson 
may be that an agreement to control NT weapons should be negotiated before any “early 
adopter” states actually acquire them, or alternatively that any such nations be required to 
relinquish their NT weapons as a condition for international agreement.    
Another lesson is that the technology transfer and assistance provisions of 
agreements like the NPT and BWC have been a strong inducement for developing 
countries to participate. These provisions require developed countries to share nuclear 
and biological information and technologies with developing countries for use in 
legitimate peaceful activities. Such provisions could provide a similar incentive for 
developing countries to enter agreements designed to control NT weapons.    
A third lesson is that arms control regimes that include a formal oversight body 
are on the whole more successful than more decentralized regimes. In particular, the 
International Atomic Energy Agency (IAEA) has played a critical role in the stability and 
effectiveness of the NPT (as evidenced by its receipt of the 2005 Nobel Peace Prize), and 
the Organization for the Prohibition of Chemical Weapons has played an equally 
effective, if less visible role in the CWC. In contrast, the lack of an oversight body in the 
BWC has led to ineffective monitoring and leaves the UN Security Council as the only 
enforcer of the convention, creating a sense of instability around the treaty.42 
A central issue in arms control is verification.3 For example, the inability of states 
to agree on a verification regime for the BWC has put the continued vitality of that treaty 
into question. The verification challenge is particularly acute for “dual use” technologies 
that can be used for both peaceful and malevolent purposes.43 For example, much genetic 
research has dual use potential, making verification and enforcement of the BWC 
problematic.44  Rather than prohibiting certain forms of biological research altogether, the 
BWC relies on a “general purpose criterion” under which restrictions depend on the 
intended use rather than the nature of the technology. Yet when a technology has both 
permissible and proscribed uses, verification becomes difficult if not impossible, at least 
without highly intrusive inspections. Governments and industry are likely to resist such 
intrusions in order to protect proprietary research.45 All of these tensions are likely to 
arise equally in the case of NT. Current attempts to address the verification problem in 
the BWC, including consideration of codes of conduct, will have relevance to any future 
agreement governing NT.  
3.  Global Ethics Treaties  
There have been a few international agreements designed to prohibit conduct held 
to violate ethical standards. In the past, most such agreements have been aimed at social 
practices, e.g., by banning the slave trade. More recently, the focus has turned toward 
governing ethical aspects of new technologies. Although these efforts have led to few 
concrete results, they still provide useful lessons for NT regulation. A prominent example 
is the recent attempt to negotiate a UN convention prohibiting human cloning.   
Although there was widespread agreement among states that reproductive cloning 
(i.e., creation of a cloned human being) should be banned, negotiations foundered over 
disagreement whether to include a ban on therapeutic cloning (i.e., derivation of 
embryonic stem cells from cloned embryos for potential therapeutic applications).46 As 
this case suggests, even with broad consensus on the desirability of restricting one 
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technological application, there may be incentives for some to expand negotiations to 
include other applications for which no consensus exists, leading to gridlock. (The 
situation is even more complex, since expanding the scope of negotiations is often 
essential to reaching agreement, as discussed above.) As the UN committee report 
cautioned, “widening the scope of the potential convention to include issues for which no 
consensus existed could threaten the entire exercise, leaving the international community 
without a coordinated legal response.”47 In the end, the General Assembly adopted a non-
binding resolution favoring a ban on both forms of cloning by a divided vote of 84 to 34 
with 37 abstentions. With this evident lack of consensus, the resolution is unlikely to 
have any practical impact.48  
The cloning precedent has obvious implications for attempts to restrict NT on 
ethical grounds. NT includes a wide variety of disparate products and processes with a 
range of risk and benefit profiles. Given that a complete prohibition on nanotechnology is 
unlikely to ever be popular, a more nuanced and hence complicated approach will be 
necessary. When the relevant inquiry is which applications should be restricted and 
which should not, there is bound to be controversy.  
Other problems encountered in the attempt to negotiate a cloning convention may 
also be relevant to NT. A second issue was whether to establish an international body to 
administer sanctions for non-compliance, or to leave it to each state to sanction non-
compliant activities within its territory. This echoes the disputes over transnational 
monitoring and sanctioning in arms control agreements. A third issue was whether any 
prohibition should be permanent or for a limited time. Proponents of limited duration 
cited the rapid pace of technological progress, which might well require periodic 
reexamination of ethical and legal issues. Similarly, with NT any future attempt at 
regulation must find a way to keep the regulatory structure current and properly aligned 
both with technological advances and with ethical perceptions and norms. 
B. A Model for the Medium Term 
As is surely clear by now, framework conventions are valuable instruments in 
situations of technical uncertainty – that is, before the risks or threats from a technology 
are sufficiently concrete to justify negotiation of legally binding, highly institutionalized 
regimes like those just discussed, but after society has recognized that some form of 
regulation, and an efficient way to implement it, may soon be needed. This point has not 
yet been reached in the development of NT, but with the pace of technical progress we 
suspect it may be reached in the relatively near future.  
As already noted, framework conventions typically contain few substantive 
obligations of the kind found in environmental or arms control treaties. Why then are 
they adopted as formal, legally binding instruments? The answer appears to be that states 
value firm commitments as to three related matters: (i) research, sharing of information, 
consultation and similar matters typically addressed in these agreements, all of which 
promote learning and incremental progress; (ii) willingness to consider more stringent 
action if and when concrete risks appear; and (iii) procedures for negotiating specific 
substantive commitments as required. These procedures are very important given the 
costs and difficulty of international negotiations. The Vienna ozone convention, for 
example, provided not only for amendment of the treaty itself, a process comparable in 
difficulty to creating a new agreement, but also for the adoption of annexes, protocols, 
decisions and other actions through streamlined procedures. In many cases, framework 
conventions provide that protocols may have different memberships than the treaty itself, 
allowing states some freedom to select the obligations to which they will submit. 
For all these reasons, a framework convention would at some point in the future 
be a valuable intermediate step in the regulation of NT.  
C. Models for the Short Term 
In the short term, it is worth considering less formal and state-based alternatives 
to legally binding transnational regulation. While time prevents a full discussion of 
possible approaches, we note here some promising models. 
• In some fields of transnational environmental regulation, independent groups 
of experts are authorized to issue periodic reports on the state of technological 
development and related issues. A prominent example is the International 
Panel on Climate Change (IPCC). The IPCC was established by UNEP and 
the World Meteorological Organization to assess scientific, technical, social 
and economic information relevant to global warming. The secretariat of the 
Framework Convention on Climate Change is directed by that agreement to 
cooperate with the IPCC. A body like the IPCC simultaneously draws on and 
strengthens relevant epistemic community(ies). So long as its independent, 
transnational, expert status is protected, such a body can develop great 
legitimacy in the public eye, and can make important contributions both to 
well-informed regulation and to the generation of political will to act. 
• Forums for information sharing and dialogue among technically expert 
national regulators are less threatening than transnational action and less 
costly than inter-state negotiations, yet they can lay a firm foundation for 
harmonized national regulation and even, if appropriate, for transnational 
regulation. Because they are decentralized, such arrangements typically need a 
convenor: a respected national agency, an international organization, or an 
NGO or professional body. The International Dialogue on Responsible 
Research and Development of Nanotechnology, described above, is an 
excellent example, already at work in the field of NT. Such arrangements face 
numerous challenges, however; these include: (i) maintaining momentum in 
the face of conflicting demands on participants; (ii) expanding participation as 
new actors enter the field; (iii) dealing with differences in capacity among 
state agencies; and (iv) avoiding capture and otherwise maintaining legitimacy 
in the eyes of governments, concerned communities and the public. 
• Non-state actors, from business firms to scientists, often establish codes of 
conduct to regulate their own conduct on a voluntary basis. Motivations for 
self-regulation can vary widely: actors may aim to establish appropriate norms 
more quickly than public institutions can act, signal their good intentions, 
engage in a public relations gesture, or forestall burdensome state regulation. 
Illustrative of business codes, Responsible Care is an initiative of the global 
chemical industry; it includes a code for the safe handling of chemicals 
throughout the product cycle, administered by national associations. Among 
scientific researchers, the Asilomar guidelines were a 1975 effort to set 
standards for responsible research in the emerging field of recombinant DNA; 
the guidelines reflected the ideals of the precautionary principle. As with 
many other private codes, portions of the guidelines were adopted by the NIH 
and other public bodies. Finally, the Foresight Guidelines are designed to 
promote the responsible development of NT-based molecular manufacturing; 
they were adopted at a 1999 workshop sponsored by two private 
organizations, the Foresight Institute and the Institute for Molecular 
Manufacturing.  
 
V. Conclusion 
While we eschew strong recommendations at this stage of our research, we see 
reasons to think that some form of transnational regulation of NT will eventually be 
thought desirable. It is likely that any formal transnational regulatory regime is many 
years in the future, but that should not prevent analysis and discussion of the challenges 
to transnational regulation, the structural choices that will have to be made, and the 
models society might look to for analogies and lessons. That is the aim of the project on 
which we have embarked. 
For purposes of discussion, after initial consideration of a wide variety of 
institutional models – ranging from informal dialogue among experts to full-blown 
treaties with international monitoring agencies – we suggest a phased approach to 
transnational regulation:  
(1) in the short term, begin with informal arrangements designed to increase and 
share knowledge of NT, its risks, and possible forms of regulation. These might 
include forums for dialogue among scientists, business firms and national 
regulators; codes of conduct informed by professional or social responsibility 
norms; and – somewhat more formally – a transnationally designated body of 
independent experts to monitor progress in the field of NT along with its social, 
economic, environmental and other impacts. 
(2) in the medium term, consider a framework convention (or more than one 
addressing different areas of concern, such as environmental and social impacts). 
The aim of such an agreement would not be to establish strong mandatory 
regulation – on the assumption that understanding of the risks of NT or the 
development of the technology would not have reached a point where that was 
called for – but rather to continue promoting research, information sharing and 
consultation, now on an inter-state basis, and to establish procedures by which the 
international community could act quickly if a need for regulation were to arise. 
(3) in the long term, consider a variety of models for more traditional forms of 
mandatory transnational regulation, bearing in mind not only the severe 
challenges those efforts have faced, but also the difficulty of translating their 
experiences to the unique field of NT. 
The overall aim would be to establish what one of us has called “pathways” to 
appropriate regulation:49 opportunities for dialogue and learning, and streamlined 
procedures, by which regulation can be developed, designed and strengthened as 
necessary to respond to the risks of NT as they appear over time – and at the same time, 
by which regulation that is too early, too stringent or ill-informed can be avoided.  
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